This looks promising- BTK Degrader: youtu.be... - CLL Support
This looks promising- BTK Degrader
Written by
Northland
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
BTK Degrader Shows Potential for Treating Refractory CLL and SLL
A novel Bruton's tyrosine kinase (BTK) degrader, NX-2127, has shown potential for treating patients...
Off BTK Inhibitors
13q Muted. Under direction of my oncologist, stopped zanubrutinib July 2022 when I caught Covid. I...
BTK Interruption & Disease Flare
I was diagnosed with stage IV accelerated SLL in January 2021 and started treatment with BTK...
ACP-196 (BTK inhibitor acalabrutinib) Trial
Well, my husband is now at the 12 month point on this trial. Bloods etc are all OK. He had a bone...
Attention Those Taking Ibrutinib & BTK Inhibitors:Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors
The publication examines the relationship between the use of ibrutinib and acalabrutinib with the...
Related Posts
New hemoncology blog looks interesting! 
BTK inhibitor challenges by Dr. Nicole Lamanna 
Looks like WW is finally over- Zanubrutinib looks promising on all fronts in first interim analysis of ALPINE Trial - Ibrutinib v Zanubrutinib in R/R CLL - report from EHA
Experience with lower dosage of BTK Inhibitors (Ibrutinib, Acalabrutinib, Zanubrutinib)
